The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
246 jobs Number of planned job losses
94 jobs Number of planned job creations
Announcement Date
21 October 2024
Employment effect (start)
21 October 2024
Foreseen end date
Description
Bayer France, part of the German Bayer Group, a multinational pharmaceutical and biotechnology company, is cutting a net total of 152 jobs. This move is part of a broader global plan aimed at reducing costs and bureaucracy, which includes 400 job cuts worldwide, with 246 in France and 94 new positions being created.
Voluntary departures will occur until around June 2025, followed by layoffs. The cuts notably impact all sectors, especially factories in Villefranche-sur-Saône, Marle-sur-Serre, Trèbes, and a research centre in Gaillard. The group's interunion comprised of the CFDT, the CGT, and FO, raised criticism over the global plan's implementation in France, which seems to only affect operational workers, instead of management like in Germany. They have currently refused to sign a preliminary agreement.
In 2023, Bayer employed 99,723 people globally. As of 2022, Bayer workforce in France was of 2 ,962.The company has undergone several internal restructurings, recorded in the European Restructuring Monitor database.
Eurofound (2024), Bayer France, Internal restructuring in France, factsheet number 201799, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/201799.